Loading…
Enanta Pharmaceuticals, Inc. is projected to rise to $15.94 by 2027, a +16% move from its current price of $13.70. ENTA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $13.34 | $13.70 | $14.06 | -0.03% |
| Jul 14 | $13.19 | $13.69 | $14.21 | -0.06% |
| Jul 15 | $13.08 | $13.69 | $14.32 | -0.10% |
| Jul 16 | $12.98 | $13.68 | $14.42 | -0.13% |
| Jul 17 | $12.90 | $13.68 | $14.50 | -0.16% |
| Jul 18 | $12.82 | $13.67 | $14.58 | -0.19% |
| Jul 19 | $12.75 | $13.67 | $14.65 | -0.22% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $12.75 | $13.67 | $14.65 | -0.22% |
| Week 2 | $12.36 | $13.64 | $15.05 | -0.45% |
| Week 3 | $12.07 | $13.61 | $15.35 | -0.67% |
| Week 4 | $11.82 | $13.58 | $15.60 | -0.89% |
| Week 5 | $11.60 | $13.55 | $15.82 | -1.12% |
| Week 6 | $11.40 | $13.52 | $16.02 | -1.34% |
| Week 7 | $11.22 | $13.49 | $16.21 | -1.56% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Enanta Pharmaceuticals, Inc. is a biotechnology company that discovers and develops small molecule drugs for virology and immunology indications. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.
It has a product pipeline that includes EDP-514 in phase 1b clinical development for chronic infection with hepatitis B virus, zelicapavir and EDP-323 in phase II for treatment of respiratory syncytovirus, EDP-235 in phase II for human coronaviruses, EDP-978 for chronic spontaneous urticaria, Glecaprevir for hepatitis C virus, and EPS-3903 for atopic dermatitis. It also has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir.
ENTA trades as Enanta Pharmaceuticals, a healthcare company with current price $14.51 and a market capitalization of $421.93M, ranking 3033 by market cap. The stock currently shows a bullish technical flavor with a 30-day price framework and a resistance at $14.51.
A major floor 32.5% below — a decisive break under it would weaken the trend.
The nearest floor, 19.2% below — buyers have tended to step in here.
The nearest ceiling, 10.3% above — a clean break opens room to run.
A major ceiling 26.5% above — clearing it would confirm fresh momentum.
Key ENTA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ENTA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $14.24 | Sell | $14.17 | Sell |
| MA 10 | $14.42 | Sell | $14.13 | Sell |
| MA 20 | $13.55 | Buy | $13.79 | Sell |
| MA 50 | $13.48 | Buy | $13.49 | Buy |
| MA 100 | $13.52 | Buy | $13.34 | Buy |
| MA 200 | $13.11 | Buy | $12.62 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.56 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | 10.68 | Neutral |
| Williams %R (14) | -81.03 | Info |
| MACD (12,26,9) | 0.04 | Buy |
| ROC (12) | -2.56 | Sell |
| Bollinger %B (20,2) | 0.53 | Neutral |
| Stochastic %K (14) | 18.97 | Buy |
| TRIX (15) | 0.39 | Buy |
| Awesome (5,34) | 1.15 | Buy |
| Ultimate (7,14,28) | 42.54 | Neutral |
| Momentum (10) | 0.25 | Buy |
| Aroon Osc (25) | 68.00 | Buy |
| Hull MA (9) | 14.05 | Sell |
| ADX (14) | 19.82 | Neutral |
| ATR (14) | 0.37 | Info |
The current technical picture is bullish with RSI at 60 and moving averages showing the stock trading above the 50-day and near the 200-day average (SMA50 at $13.33; SMA200 at $12.85). The immediate support is listed at $11.07 and resistance at $14.51, indicating a near-term ceiling close to the current price. Over the last 30 days, the price has traded between $11.97 and $17.60, reflecting a relatively wide swing potential.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $11.07 | $13.70 | $16.27 | 0% | Neutral | |
| $12.73 | $15.94 | $21.07 | +16% | Neutral | |
| $15.22 | $19.56 | $26.81 | +43% | Bullish | |
| $15.84 | $20.81 | $29.33 | +52% | Bullish | |
| $17.27 | $23.15 | $33.40 | +69% | Bullish | |
| $17.17 | $23.42 | $34.49 | +71% | Bullish | |
| $17.39 | $24.12 | $36.19 | +76% | Bullish | |
| $18.96 | $26.71 | $40.74 | +95% | Bullish | |
| $19.77 | $28.26 | $43.78 | +106% | Bullish | |
| $23.56 | $34.15 | $53.67 | +149% | Bullish | |
| $28.01 | $43.27 | $72.22 | +216% | Bullish | |
| $51.21 | $88.21 | $160.70 | +544% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $11.07 | $13.70 | $16.32 | +0.00% |
| August 2026 | $11.28 | $13.30 | $16.09 | -2.90% |
| September 2026 | $11.21 | $13.31 | $16.27 | +0.02% |
| October 2026 | $11.36 | $13.56 | $16.73 | +1.92% |
| November 2026 | $11.06 | $13.27 | $16.50 | -2.12% |
| December 2026 | $10.78 | $13.00 | $16.27 | -2.09% |
Click any year to see its month-by-month ENTA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ENTA to range from $11.07 to $16.27 through 2026. The $13.70 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The ENTA price prediction for 2027 points to an average of $15.94 (low $12.73, high $21.07) — a potential gain of +16% on today's $13.70. Price action looks broadly range-bound.
In 2028, ENTA is projected to trade between $15.22 and $26.81, averaging $19.56 — a potential gain of +43% from today's $13.70. That is up +23% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Enanta Pharmaceuticals, Inc.'s 2029 outlook centres on $20.81, within a $15.84 to $29.33 range. That is up +6% on the projected 2028 average. That marks a +52% change versus current levels. Momentum favours further upside here.
By 2030, ENTA could reach as high as $33.40, with a base case around $23.15 and support toward $17.27 — roughly +69% from $13.70. Buyers look set to stay in control over this stretch.
Expect ENTA to range from $17.17 to $34.49 through 2031. The $23.42 average target implies a +71% move from current prices. That is up +1% on the projected 2030 average. Momentum favours further upside here.
The ENTA price prediction for 2032 points to an average of $24.12 (low $17.39, high $36.19) — a potential gain of +76% on today's $13.70. Buyers look set to stay in control over this stretch.
In 2033, ENTA is projected to trade between $18.96 and $40.74, averaging $26.71 — a potential gain of +95% from today's $13.70. That is up +11% on the projected 2032 average. Momentum favours further upside here.
Enanta Pharmaceuticals, Inc.'s 2034 outlook centres on $28.26, within a $19.77 to $43.78 range. That is up +6% on the projected 2033 average. That marks a +106% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, ENTA could reach as high as $53.67, with a base case around $34.15 and support toward $23.56 — roughly +149% from $13.70. Momentum favours further upside here.
Expect ENTA to range from $28.01 to $72.22 through 2040. The $43.27 average target implies a +216% move from current prices. That is up +27% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The ENTA price prediction for 2050 points to an average of $88.21 (low $51.21, high $160.70) — a potential gain of +544% on today's $13.70. Momentum favours further upside here.
Investing $1,000 in ENTA today (≈ 72.992701 ENTA) could be worth
$6,439
+$5,439 (+544%) by 2050 · US Dollar
Based on the average projected ENTA price of $88.21 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ENTAwould be worth at today's price.
$1,000 invested in ENTA on Jul 10, 2025 (≈ 143.266475 ENTA) would be worth
$1,962.75
+$962.75 (+96.3%) today · 1.96× · US Dollar
Based on a ENTA entry price of $6.98 vs. today's $13.7.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $15.11 | $906.68 | -9.3% |
| 1 month ago | $11.7 | $1,170.94 | +17.1% |
| 3 months ago | $14.11 | $970.94 | -2.9% |
| 6 months ago | $12.91 | $1,061.19 | +6.1% |
| 1 year ago | $6.98 | $1,962.75 | +96.3% |
| All time (5.0y) ago | $41.88 | $327.13 | -67.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ENTA forecast.
Our base-case forecast reaches $27.00 around 2034.
Implied market cap at $27.00: $785.12M
Long-term forecasts project a transition to bullish sentiment after 2026, with the average price climbing from $14.51 in 2026 to higher levels in subsequent years. The 2027 forecast shows an average of $17.93 with a 23.6% ROI; by 2028 the average is $22.23 with a 53.2% ROI, and by 2030 the average is $26.96 with an 85.8% ROI. The trajectory continues through 2031 ($27.09, 86.7%), 2032 ($28.36, 95.5%), and 2033 ($32.04, 120.8%), reaching $34.09 on average in 2034 with a 134.9% ROI and $42.57 on average in 2035 with a 193.4% ROI.
By 2040 the average is $53.42 with a 268.2% ROI, and by 2050 the average rises to $114.74 with a 690.8% ROI. These figures imply substantial upside over the long run, but they are estimates and not guarantees.
Tap a question to reveal the answer.
The average forecast price in 2030 is $26.96, with a minimum of $19.72 and a maximum of $39.81. The projected ROI is 85.8%.
Forecasts show bullish sentiment from 2027 onward with rising average prices and positive ROI, including 2027 ($17.93, 23.6%), 2030 ($26.96, 85.8%), and 2050 ($114.74, 690.8%). These are estimates, not guarantees.
Yes. The forecast maximum reaches $50.25 in 2033, with higher later years such as $54.37 in 2034 and beyond (e.g., $92.31 in 2040, $217.77 in 2050).
The 30-day range is $11.97 to $17.60.
Current price is $14.51 and market cap is $421.93M; the rank is 3033.
Enanta Pharmaceuticals, Inc. Community Discussion
0Share your Enanta Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.